Chronic obstructive pulmonary disease in farmers and agricultural workers - an overview

Annals of Agricultural and Environmental Medicine

Volumn 18, Issue 2, 2011, Pages 310-313

  Szczyrek, Michał ^a   Krawczyk, Paweł ^a   Milanowski, Janusz ^a,b   Jastrzebska, Iwona ^a   Zwolak, Agnieszka ^a   Daniluk, Jadwiga ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

Agriculture; COPD; Epidemiology; Exposure; Farmers; Organic dust

Indexed keywords

BRONCHODILATING AGENT; GLUCOCORTICOID; NICOTINIC CHOLINERGIC RECEPTOR ALPHA3; NICOTINIC CHOLINERGIC RECEPTOR ALPHA5; NICOTINIC RECEPTOR; UNCLASSIFIED DRUG;

AGRICULTURAL WORKER; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; FUNCTIONAL STATUS; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HHIP GENE; HUMAN; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG RESECTION; LUNG TRANSPLANTATION; MORBIDITY; MORTALITY; NONINVASIVE VENTILATION; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; ORGANIC DUST; OXYGEN THERAPY; PATHOGENESIS; PULMONARY REHABILITATION; QUALITY OF LIFE; REVIEW; RISK FACTOR; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

ADULT; AGRICULTURAL WORKERS' DISEASES; AGRICULTURE; DUST; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; POLAND; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY SYSTEM; RISK FACTORS; SMOKING;

EID: 84859134152     PISSN: 12321966     EISSN: 18982263     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Barr RG, Bluemke DA, Ahmed FS, et al. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med 2010;362:217-227.
2. Feary JR, Rodrigues LC, Smith CJ, et al. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax 2010, 65:956-962.
3. Ferguson GT, Calverley PM, Anderson JA, et al. Prevalence and progression of osteoporosis in patients with COPD: results from the Towards a Revolution in COPD Health study. Chest 2009;136:1456-1465.
4. Hung WW, Wisnivesky JP, Siu AL, Ross JS. Cognitive decline among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009;180:134-137.
5. Incalzi RA, Corsonello A, Pedone C, et al. Chronic renal failure: a neglected comorbidity of COPD. Chest 2010;137:831-838.
6. Light RW, Merrill EJ, Despars JA, et al. Prevalence of depression and anxiety in patients with COPD. Relationship to functional capacity. Chest 1985;87:35-38.
7. Schneider C, Jick SS, Bothner U, Meier CR. COPD and the risk of depression. Chest 2010;137:341-347.
8. Sin DD, Man SF: Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc 2005;2:8.
9. Watz H, Waschki B, Meyer T. Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation. Chest 2010;138:32-38.
10. Kozielski J, Chazan R, Górecka D, Jahnz-Rózyk K, Jedrychowski W, Kuna P, et al. Zalecenia Polskiego Towarzystwa Fizjopneumonologicznego rozpoznawanie i leczenie przewlekłej obturacyjnej choroby płuc. (Diagnosis and therapy of chronic obstructive pulmonary disease-recommendations of the Polish Phtisiopneumonology Society). Pneumonol Alergol Pol 2002;70 sup. 2:2-42 (in Polish).
11. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997;349(9063):1436-1442.
12. Atsou K, Chouaid C, Hejblum G. Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review. BMC Med 2011;9:7.
13. Antó JM, Vermeire P, Sunyer J. Chronic obstructive pulmonary disease. Eur Respir Monogr 2000;5(15):1-22.
14. Pływaczewski R, Bednarek M, Jonczak L, Zieliński J. Prevalence of COPD in Warsaw population. Pneumonol Alergol Pol 2003;71(7-8):329-335.
15. Ezzati M. Indoor air pollution and health in developing countries. Lancet 2005;366(9480):104-106.
16. Regalado J, Perez-Padilla R, Sansores R, Paramo-Ramirez JI, Brauer M, Pare P, Vedal S. The Effect of Biomass Burning on Respiratory Symptoms and Lung Function in Rural Mexican Women. Am J Respir Crit Care Med 2006;174(8):901-905.
17. Eduard W, Pearce N, Douwes J. Chronic bronchitis, COPD, and lung function in farmers: the role of biological agents. Chest 2009;136(3):716-725.
18. Dalphin JC, Bildstein F, Pernet D, Dubiez A, Depierre A. Prevalence of chronic bronchitis and respiratory function in a group of dairy farmers in the French Doubs province. Chest 1989;95(6):1244-1247.
19. Greskevitch M, Kullman G, Bang KM, Mazurek JM. Respiratory disease in agricultural workers: mortality and morbidity statistics. J Agromedicine 2007;12(3):5-10.
20. Monsó E, Riu E, Radon K, Magarolas R, Danuser B, Iversen M, Morera J, Nowak D. Chronic obstructive pulmonary disease in never-smoking animal farmers working inside confinement buildings. Am J Ind Med 2004;46(4):357-362.
21. Badgett RG, Tanaka DJ, Hunt DK, et al. Can moderate chronic obstructive pulmonary disease be diagnosed by historical and physical findings alone? Am J Med 1993;94:188-196.
22. Sethi S, Murphy TF: Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 2008;359(22):2355-65.
23. Pillai SG, Ge D, Zhu G, Kong X, Shianna KV, et al. A Genome-Wide Association Study in Chronic Obstructive Pulmonary Disease (COPD): Identification of Two Major Susceptibility Loci. PLoS Genet 2009;5(3): e1000421.
24. Wilk JB, Chen T-h, Gottlieb DJ, Walter RE, Nagle MW, et al. A Genome-Wide Association Study of Pulmonary Function Measures in the Framingham Heart Study. PLoS Genet 2009; 5(3):e1000429.
25. Van Durme YM, Eijgelsheim M, Joos GF, Hofman A, Uitterlinden AG, Brusselle GG, Stricker BH. Hedgehog-interacting protein is a COPD susceptibility gene: the Rotterdam Study. Eur Respir J 2010; 36(1):89-95.
26. Obeidat M, Wain LV, Shrine N, Kalsheker N, Artigas MS, et al. A Comprehensive Evaluation of Potential Lung Function Associated Genes in the SpiroMeta General Population Sample. PLoS ONE 2011; 6(5):e19382.
27. Sahlander K, Larsson K, Palmberg L. Altered innate immune response in farmers and smokers. Innate Immun 2010; 16(1):27-38.
28. Sundblad BM, von Scheele I, Palmberg L, Olsson M, Larsson K. Repeated exposure to organic material alters inflammatory and physiological airway responses. Eur Respir J 2009; 34(1):80-88.
29. Milanowski J. The influence of organic dust on the chemotaxis of lung cells. Experimental studies. Pneumonol Alergol Pol 1996; 64 Suppl 1:78-89.
30. Milanowski J, Sorenson WG, Lewis DM, Dutkiewicz J. Chemotaxis of alveolar macrophages and neutrophils in response to microbial products derived from organic dust. J Investig Allergol Clin Immunol 1995; 5(4):221-227.
31. Golec M, Reichel C, Mackiewicz B, Skorska C, Curzytek K, Lemieszek M, et al. Cathelicidin LL-37, granzymes, TGF-beta1 and cytokines levels in induced sputum from farmers with and without COPD. Ann Agric Environ Med 2009; 16(2):289-297.
32. Hospers JJ, Postma DS, Rijcken B, et al. Histamine airway hyperresponsiveness and mortality from chronic obstructive pulmonary disease: a cohort study. Lancet 2000; 356:1313.
33. Breen D, Churches T, Hawker F, Torzillo PJ. Acute respiratory failure secondary to chronic obstructive pulmonary disease treated in the intensive care unit: a long term follow up study. Thorax 2002; 57:29-33.
34. Seneff MG, Wagner DP, Wagner RP. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. JAMA 1995; 274:1852.
35. Martin TR, Lewis SW, Albert RK. The prognosis of patients with chronic obstructive pulmonary disease after hospitalization for acute respiratory failure. Chest 1982; 82:310-314.
36. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555.
37. Rice KL, Dewan N, Bloomfield HE, Grill J, Schult TM, Nelson DB, et al. Disease management program for chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med 2010; 182(7):890-896.